The Mahatma Gandhi Institute of Medical Sciences is India’s first rural medical college, nestled in the karmabhoomi of Mahatma Gandhi, in Sevagram. It is managed by the Kasturba Health Society.

During the past decade, Mahatma Gandhi Institute of Medical Sciences conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mahatma Gandhi Institute of Medical Sciences" #1 collaborator was "Government Medical College, Nagpur" with 3 trials as a collaborator, "Daga Memorial Maternity and Children's Hospital, Nagpur, India" with 2 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 2 trials as a collaborator, "Indira Gandhi Government Medical College & Hospital, Nagpur, India" with 2 trials as a collaborator and "Pimpri Chinchwad Municipal Corporation's Post-Graduate Institute, Yashwantrao Chavan Memorial Hospital, Pune, India" with 2 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Mahatma Gandhi Institute of Medical Sciences" are "Birth Asphyxia" (2 trials), "Hypoxic-Ischemic Encephalopathy" (2 trials), "COVID-19" (1 trials), "Fibromyalgia" (1 trials) and "Induction of Labor" (1 trials). Many other conditions were trialed in "Mahatma Gandhi Institute of Medical Sciences" in a lesser frequency.

Most popular intervention types in "Mahatma Gandhi Institute of Medical Sciences" are "Other" (3 trials), "Drug" (2 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Amitryptiline" (1 trials), "Hyperthermia" (1 trials), "Low dose radiotherapy" (1 trials), "Oral misoprostol" (1 trials) and "Oxytocin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mahatma Gandhi Institute of Medical Sciences" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Mahatma Gandhi Institute of Medical Sciences". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Mahatma Gandhi Institute of Medical Sciences, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mahatma Gandhi Institute of Medical Sciences, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".

Mahatma Gandhi Institute of Medical Sciences has several departments that took part in Clinical trials: "Department of community Medicine, Dr Sushila Nayar School of Public Health, Mahatma Gandhi Institute of Medical Sciences, Sewagram" - 2 trials